Tag Archives: Regeneron39s

[ad_1] Regeneron Pharmaceuticals (REGN) is about 18 months ahead of Merck (MRK) in the use of immunotherapy to treat a form of skin cancer, announced analysts after Libtayo's approval by Regeneron. X …

[ad_1] The main problem Regeneron (REGN) has enjoyed tremendous success in the stock market for almost 7 years since the approval of its mega-blockbuster drug for retinal diseases, Eylea, by the FDA. …